Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Approaches for Identifying Molecular Targets in Liver Disease

NCT03915002 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT03915002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03915002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Approaches for Identifying Molecular Targets in Liver Disease
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Completed
Start date
June 13, 2019
Completion date
April 12, 2023
Enrollment
155 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic liver disease, non-alcoholic fatty liver disease, steatohepatitis, steatohepatitis, nonalcoholic